Neurocrine Biosciences
NBIX83
$119.69arrow_drop_up0.53%$0.63
High Quality
High Growth
NBIX83
$119.69
arrow_drop_up0.53%
There's no data available for key stats
There's no data available for ratios/profitability stats
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
NBIX-
US Healthcare Sector-
US Market-
check_circle
NBIX / Market
NBIX exceeded the US Market which returned 0.03% over the last twenty four hours.warning
NBIX / Healthcare Sector
NBIX lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.Neurocrine Biosciences (NBIX) Statistics
Keep an eye on Neurocrine Biosciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the EPS of Neurocrine Biosciences (NBIX) stock?
The Earnings Per Share (EPS) for Neurocrine Biosciences (NBIX), calculated on a diluted basis, is $3.29. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Neurocrine Biosciences (NBIX) stock?
The operating margin for Neurocrine Biosciences (NBIX) is 20.87%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Neurocrine Biosciences (NBIX) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Neurocrine Biosciences (NBIX) is $588.9M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Neurocrine Biosciences (NBIX) have?
Neurocrine Biosciences (NBIX) has a total debt of $495.7M. The net debt, which accounts for cash and cash equivalents against the total debt, is $222.1M.
help
How has Neurocrine Biosciences (NBIX) stock's performance compared to its sector and the market over the past year?
Over the past year, Neurocrine Biosciences (NBIX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Neurocrine Biosciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Neurocrine Biosciences 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Neurocrine Biosciences (NBIX) stock?
The PE (Price to Earnings) ratio of Neurocrine Biosciences (NBIX) is currently 36.38. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.